CLBT
Cellebrite DI Ltd.
NASDAQ · Technology · Software - Infrastructure · IL
$11.45
−4.10%Year over year
Reported trailing growth
- Revenue
- +17.8%
- EBITDA
- +22.2%
- EBIT
- -8.6%
- EPS
- +131.1%
- Free cash flow
- -6.3%
- Operating cash flow
- -5.0%
Forward estimates
Based on analyst estimates
- Revenue
- +16.6%
- EBITDA
- +6.3%
- EPS
- +38.9%
Three-year CAGR
- Revenue
- +20.7%
- EBITDA
- -7.5%
- EBIT
- +299.3%
- Net income
- -13.4%
- EPS
- -21.5%
- Free cash flow
- +138.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026